This paper measures high medical expenses in ten developed countries, both overall and by income and age, providing some of the best evidence to date on the extent of high medical spending across and within countries. Using comparable household-level data on out-of-pocket (OOP) medical expenditures made available through the Luxembourg Income Study (LIS), we measure high spending when it exceeds a threshold share of household income. The results show that the U.S. is far from alone in its failure to protect individuals from large medical expenses. In five of the other nine countries, one-quarter or more of poor households devoted at least 5 percent of household income to OOP expenses. The rate of high spending in the US is similar to Japan's, but below that in Russia, Poland, Israel, and Switzerland. The high levels of exposure to large medical expenses in most countries indicates the need to develop robust measures of excessive spending that capture both future risk as well as past burdens. 
In recent years, many health care systems have increased their reliance on individuals paying out-of-pocket to finance their country's health care.
1, 2 Among Americans covered by employer-offered health insurance, the percent with deductibles of at least $1,000 grew from 10 to 41 percent between 2006 and 2014, and deductibles for one-in-five now stand between $2, 000 and $4,500. 3 This paper investigates the degree to which health care systems in ten countries place high financial burdens on their citizens, focusing particularly on the poor and elderly, two groups especially vulnerable to high health care costs. By using comparable nationally-representative household level data from 2010 on both income and out-of-pocket (OOP) spending, the study provides some of the best evidence to date on the extent of high medical spending across and within countries. Measuring OOP spending relative to income, the analysis shows that in half of the sample countries, more than 10% of the population lived in households with high medical expenses, and in seven countries more than a quarter of the poor did. While high spending is more common among the poor than the elderly, in eight countries more than one-in-ten elderly citizens lived in households with high medical expenses.
The results underscore the very high burden medical expenses place on Americans. But so too do they show that high spending is equally common among the poor and elderly in about half of the countries in our sample. The paper concludes that assessments of national health care systems' performance should include measures of high spending risks, especially important as pressure on private and social insurance schemes mounts. Equity in the financing of health care, as well as in access and outcomes, depends on ensuring that OOP spending does not become excessive.
A. Overview
The design of health insurance coverage, and the role of OOP payments in it, has become a key policy concern in many countries as rising health care expenses encourages the expansion of greater cost-sharing measures (Collins, Rasmussen, Doty, and Beutel, 2014; Tambor et al 2011; OECD 2013) . Relying on the direct users of health care to pay some (or occasionally even all) of their medical expenses can help reduce the moral hazard associated with insurance, and in many instances paying out-of-pocket can be fair as some health expenses reflect individual preferences and income instead of medical necessity. Some forms of cost sharing can also improve efficiency if they reduce the administrative costs necessitated by third party payers.
Despite these potential benefits, OOP requirements can create inequitable burdens when the level requires forgoing essential household spending, or taking on high debt that can lead to bankruptcy (Himmelstein 2009). Most troubling is when it leads to delaying or forgoing medical care, pharmaceutical products, and other needed medical goods (Eaddy et al. 2012) , and outcome more common among the poor (Tamblyn et al 2001 , Lesen et al 2013 Schoen et al 2010 , Chernew et al 2008 , elderly (Tamblyn et al 2001) , and those with chronic health problems (Hirth et al 2008; Rector and Venus 2004) .
Out-of-pocket medical spending is commonly defined in one of two ways. Most frequently, it is measured by the costs to individuals of purchasing medical goods and services through co-pays, co-insurance and deductibles; the expenses of those without health insurance; and the cost of goods and services not covered by insurance. A second, more comprehensive definition includes individuals' payments for insurance premiums. References to OOP spending in this paper refer to the first definition as this captures the unknown and risky component of health care spending, and is what can deter individuals from consuming appropriate levels of health care.
All countries rely to some degree on OOP expenditures to fund their health care system. According to the Organization for Economic Cooperation and Development (OECD), on average OECD member countries use OOP payments to fund 19 percent of their health care expenditures (Exhibit 1). Perhaps surprisingly, the U.S. depends on cost sharing less than do many countries, as it accounts for only 12 percent of total health spending. However, average per-capita dollar amounts in the U.S. are similar to those in other countries (Exhibit 1).
Exhibit 1 about here
The central concern with OOP spending is not with country-level averages, however, but with the potential burden it places on individual households. A common gauge of this risk, sometimes referred to in the literature as underinsurance, is when households' OOP spending exceeds a particular share of income-most commonly 10 percent, or 5 percent if the household is poor (Ziller et al 2006; Schoen et al. 2010; Collins et al. 2014; Cunningham 2009 ).
1 One shortcoming of this indicator is that it is a retrospective one, measuring the burden of actual health care expenses as opposed to the prospective risk of incurring them.
2
Using this measure in the United States has revealed that a large percentage of Americans are underinsured. Ziller et al (2006) estimate that 63 percent of America's poor households were underinsured, while Collins et al. (2014) estimate that 40 percent of nonelderly, poor adults with health insurance are underinsured. High spending is also common among Americans in poor health (Cunningham 2009) , and the elderly.
3 Studies of the financial burden of OOP spending in other countries finds that it is often high, but also that it varies significantly (Schoen 2010; Tambor et al 2011 and 2013; Xu et al 2007) .
The OECD and World Bank provide country-level estimates of per-capita OOP spending (Exhibit 1). However, their figures are based on nations' responses to health-financing questionnaires, 4 and do not permit disaggregation to the household level; nor do they allow comparing the size of OOP health expenditures among different demographic groups, such as the elderly, the poor, or those in poor health.
1 "Catastrophic" medical spending is sometimes similarly defined, although it also occasionally relies on a higher threshold (Xu et al 2007) . 2 Some researchers attempt to combine the two concepts by including in the numbers those without insurance and/or those with deductibles above a certain share of income (Collins et al 2014) . 3 Marshall, McGarry and Skinner (2010) Such lack of comparable data has hindered cross-national research on the financial burden of OOP expenses at the household level. As a rare exception, Schoen et al (2010) used telephone calls to collect primary data from thousands of randomly-selected citizens in eleven countries. Inquiring into households' OOP spending, they matched these levels with conjectures over the respondents' income, finding that high spending (above $1,000/year) was common in the US, with Switzerland close behind, concluding that by international standards, the U.S. was an "outlier" when it comes to cost-sharing (Schoen, p. 2333). Another international comparison used OOP spending data from a large international sample of hemodialysis patients (Hirth et al 2008) ; the researchers found that among eleven countries, patients paid about twice the amount OOP on prescription medications than was the average in the other ten countries.
Other than through such examples as these, we know little about how countries compare in the degree to which citizens are exposed to the risk of high medical expenses. More rigorous and comprehensive cross-national data would improve assessments of the relative performance of health care systems and the inequities within them.
B. Study Data and Methods
To develop comparable international indicators of the degree to which national health care systems place individuals at financial risk, we use household OOP spending from national household budget survey (HBS) data made available through the Luxembourg Income Study (LIS). LIS produces harmonized versions of HBSs by aligning variables with international standards to encourage cross-national research. Numerous LIS datasets include OOP spending data; this paper excluded those where estimates differed significantly from OECD figures (Hungary and Italy), where the definition of OOP spending deviated from standard practice (Taiwan), where the data were old (Estonia and Romania), and where the country's income was low relative to the United States (China, Guatemala, India, Mexico, Peru, Serbia, and South Africa). Ten countries remained: Canada, France, Australia, Israel, Japan, Poland, Russia, the U.S., Slovenia, and Switzerland. For all countries except Japan Switzerland (2004) , the household data comes from calendar year 2010.
For the United States, LIS data originates with the Current Population Survey's Annual Social and Economic Supplement (CPS). Among the ten countries in this study, the U.S. is unique in providing separate household spending data on both premiums and non-premium (OOP) expenses. CPS's OOP spending data has been found comparable to the Medical Expenditure Panel Survey's (MEPS) data, generally viewed as the U.S.'s best source for household OOP spending (Cohen et al., 2009 ). The CPS also offers three advantages over the MEPS: its sample size is five times larger; it provides better estimates of household expenditures on insurance premiums (Caswell and O'Hara 2010) ; and it contains much more detailed and accurate information on household income.
All Medical spending data from all countries except Canada measure households' OOP spending only; Canada's includes OOP spending plus the cost of private health insurance premiums. Because of this discrepancy, medical spending in the U.S. is measured both with premiums (designated by US*) and without; the "with" measure is used exclusively for comparisons with Canada. The sample size of observations used ranged from 7,938 in Switzerland to 203,799 in the United States. In most countries, we used nearly the entire set of observations, but in three, more than 25 percent of observations were missing key variables and were dropped. Appendix A provides detail on each country's data set and variables.
Definitions
Out-of-pocket spending: The LIS variable "consumption of health," measures total household expenditures on medical products, appliances and equipment, outpatient services and hospital services, excluding payments for health insurance. LIS does not verify or enforce compliance with its definition, and there is some variation among countries in what they include, as indicated by the example Canada above.
Because of potential inconsistencies or inaccuracies in estimates of household OOP derived from HBSs (Heijink et al 2010) , we first compared estimates of per-capita OOP spending from LIS with those from the OECD (or in the case of Russia, the World Bank). Column 3 in Exhibit 1 presents LIS's estimate, and Column 4 shows it relative to the OECD's (column 1). As shown, LIS's estimate for Canada is noticeably above the OECD's, which is to be expected since LIS's includes private insurance spending. For all other countries, LIS estimates fall between 68 and 96 percent of the OECD's. These discrepancies can be at least partly explained by two differences between the two sources: household budget surveys generally exclude the institutionalized population (e.g., those in long-term care facilities) as well as individuals who died earlier in the year; for both these populations, OOP spending can be significant (Marshall, McGarry and Skinner 2010; Cubanski et al. 2014 ).
Such differences indicate one shortcoming of using nations' HBSs for OOP estimating household-level OOP spending. However, there are few good alternatives, especially for comparative purposes, and LIS data present a unique opportunity for the latter. While downwardly biased, LIS's validation with OECD data indicates that a reasonable degree of trustworthiness. And as mentioned earlier, LIS's OOP spending data for the U.S. is of especially good quality. Moreover, LIS's income data is excellent and highly consistent across countries.
Income. To measure the resources available to pay for medical expenses, we define income as disposable income, meaning income after accounting for government taxes and social transfers. As with OOP spending, income is measured at the household level.
To examine the burden medical spending places among households with different incomes, we also classify each country's population into four income categories. For this purpose, we use the equivalized form of household disposable income (disposable income divided by the square root of household size) to account for economies of scale in household size. All members of the same household are assigned identical values of equivalized income. The four income categories are "extreme poverty," if equivalized disposable income falls below 40 percent of the nation's median value; "poverty" is measured using the European Commission's definition of income below 60 percent of the median; 5 "near poor" for those with income falling in the range of 60 to 100 percent of median income; and "above median income", which consists of 50 percent of the population. Exhibit 1 columns 5-8 show the percentage of citizens in each country falling within each income category.
High Medical Expenses. We measure high OOP spending (frequently called underinsurance) by calculating household health expenses as a share of household income. If this exceeds 10 percent--or 5 percent if the person is in poverty-then all individuals in the household are regarded as having high medical expenses. This measure is conservative because it employs an ex-post definition rather than citizens' ex-ante exposure to high medical expenses. It also entails an arbitrary division between the "poor" and the "non-poor:" someone with 59 percent of median income is poor, whereas another with 61 percent is not. Our measurement of high spending is also conservative because it does not capture those who register low OOP spending because they defer or forgo medical treatment rather than paying the cost. Finally, as discussed above, LIS estimates of OOP spending are below the OECD's, and therefore likely underestimate the phenomenon of high medical spending, particularly among the elderly population.
Our measurement of high spending could overestimate its incidence for a couple of reasons. One, we do not consider household wealth, and especially among the elderly, wealth makes otherwise high levels of OOP affordable. Second, we only measure OOP spending in a single year, and many households may be capable of smoothing out one year of high medical expenses. High OOP spending is most problematic when it is either very high, or persists over time; our estimates take no account of such distinctions. Age. We investigate high spending among the elderly (65 and over) and non-elderly population (below 65); among the elderly, we further distinguish between 65 to 74 years-olds and those 75 and over.
C. Study Results
Exhibit 2 presents country-level estimates of the frequency of high medical expenses in each of the countries during the study year. Rates for the US* and Canada are based on premium and non-premium expenses; for the US and all the other countries, it is based on OOP spending only. Comparing the US* with Canada reveals that over four times more Americans than Canadians had high medical expenses in 2010 (26 versus 6 percent, see Appendix B for more detail). In five nations (U.S., Poland, Israel, Switzerland and Poland), more than 10% of individuals lived in households with high medical spending. Only France had less than 5% of its population with high spending, although Canada is a close second.
 High Spending Rates by Income
To explore how the financial burden of health care consumption varies by income, we calculate high-spending rates within the four income groups discussed above. Exhibit 3 displays estimates of underinsurance rates for each of these four income classifications, showing a strong negative association within countries between income and the frequency of high spending. The significantly lower rates among the near-poor compared with the poor is partially an artifact of measurement (spending exceeding 10 percent of income among the former but only 5 percent among the latter). However, in all countries underinsurance rates are lower among those with above-median income compared with the near-poor, and only in Israel and the US* are rates among those in extreme poverty slightly below the rate of those in poverty--perhaps reflecting underutilization of services within this group rather than superior insurance.
<Exhibit 3 here>
Pronounced income-based differences in underinsurance rates are apparent in every country; the difference in rates between those in extreme poverty and those with above-median income is lowest in France (16.4 percentage points) and largest in Japan and Australia (35.6 and 34.5 percentage points respectively), with the United States (27.5 percentage point difference) just above the average. In absolute terms, those in poverty in France are the least likely (11.5 percent) to have high medical expenses.
The results reveal that a large share of poor Americans were underinsured in 2010. Counting the cost of insurance, 40 percent had high medical expenses; not counting it, more than one-in-four (28.7 percent) did. This latter rate is similar to those in Japan, Australia and Poland, but lower than those in Israel and Switzerland. Only France (11.5 percent) and to a lesser extent Slovenia, had significantly lower rates. Including the cost of insurance, poor Americans are more than twice as likely as poor Canadians to have high medical expenses (40 versus 17.4 percent). Rates of underinsurance among all income groups of Americans jump significantly once accounting for the expense of insurance premiums, but the increase is particularly marked among the near poor, where the percentage of high spenders increases from 11.1 to 29.7 percent (see Appendix B).
 Underinsurance Rates by Age
Exhibit 4 compares underinsurance rates for the non-elderly (below 65), the youngelderly (between 65 and 74), and the old-elderly (75 and above). With two minor exceptions (Slovenia and Japan), underinsurance rates increase with age, with this growth most pronounced in Switzerland (29.9 percentage point difference), Poland (24 percentage points) and the United States* (21.9 percentage points). Unlike with income, however, age-related differences in rates are small in some countries, with a less than 10 percentage point difference in Canada, France, Slovenia and Japan.
<Exhibit 4 here>
The underinsurance rate among America's 65 to 74 year-olds (18.2 percent) is similar to rates in Japan and Australia, but considerably below those in Poland, Russia, Israel and Switzerland. France (2.7 percent) has by far the lowest rate, followed by Slovenia (15 percent). Accounting for premium expenses and compared with their Canadian counterparts, older Americans were nearly four times more likely to have high medical expenses in 2010 (37.7 versus 9.6 percent).
Comparing underinsurance rates in the US with and without insurance premiums reveals the premium's disproportionate burden on the elderly. With this inclusion, underinsurance rates among the non-elderly increase from 10.9 to 23.7 percent, but grow by a considerable 19.5 percentage points among 65 to 74 year-olds, and then double from 23.2 to 45.6 percent among the 75 and older population.
D. Discussion
These estimates provide some of the best comparative evidence to date of variation within and between countries in the percentage of citizens exposed to high medical expenses. In seven of the ten countries (U.S., Japan, Australia, Poland, Israel, Russia, and Switzerland), onequarter or more of poor households devoted at least 5 percent of their income to non-premium expenses; and in no country did fewer than one-in-ten poor citizens experience high medical costs. Underinsurance rates among the elderly are somewhat lower, yet we find that one-in-four elderly citizens had high spending in Switzerland, Russia, Poland and Israel, while more than 15 percent did in Australia, Slovenia, Japan and the US. Prior cross national research indicates Americans are the most exposed to OOP spending (Schoen et al 2010; Hirsch et al 2008) ; yet the results here indicate high levels of spending are far from limited to the U.S. Looking strictly at the poor and elderly populations, we find similar or larger underinsurance rates in Slovenia, Japan, Poland, Israel, Russia and Switzerland. These numbers are especially alarming because they likely underestimate, perhaps by a considerable degree, citizens' true exposure to the risk of high medical expenses. The estimates indicate that the degree of protection from high OOP spending provided in France and Canada is rare.
That high OOP spending in the U.S. is on par with its scale in about half of the study's countries could overlook the extreme levels of spending to which Americans are uniquely exposed. While the 90 th percentile of OOP expenses as a share of income among both the poor and elderly are similar in the US, Poland, Israel, and Russia, and is much larger in Switzerland (see Appendix B), it is still possible (even probable) that America's extreme tail of the spending distribution lies significantly beyond those in other countries (see Cohen and Yu 2012) .
A second reason to question the similarity we find between the U.S. and other countries is that (except for Canada) country-level comparisons are based on non-premium OOP spending, which sidesteps Americans' significant expenditures for health insurance. While private insurance pays for 35 percent of America's health expenses, it pays less than 10 percent in five of the nine other countries (Exhibit 1 Column 9). It could be argued, then, that a more accurate cross-national comparison of health care's financial burden should include Americans' distinctly high expenditures on insurance premiums.
Addressing this claim extends beyond the scope of this paper. But were we to make this adjustment, we indeed find that one-in-four Americans had high medical expenses in 2010, a rate far exceeding those in the other nine countries (Exhibit 2). Yet as Exhibit 3 showed, even with this broader measure of Americans' medical spending, few countries provided their poorest citizens with far superior protection, and among the elderly population, several countries approach the financial burden America's elderly face. What may distinguish the U.S., then, is the extent to which the cost of premiums push middle class and non-elderly populations into the category of high medically-related spending.
E. Policy Implications
Out-of-pocket medical expenditures place significant financial burdens on large numbers of people across the ten countries in this study. Given the strong evidence that cost-sharing can cause individuals to forgo health care and not adhere to recommended drug therapies, the magnitude of high medical spending we uncover implicates OOP requirements not just in financing inequities, but also in contributing to inequitable access to health care and medical outcomes.
Such effects on core features of nations' health care systems point to the clear need to better monitor high medical spending at the household level. Such monitoring, though, requires two important developments. First is the need to grapple with defining when the financial burden of health expenses becomes excessive. The "underinsurance" measure used in this paper is common in the literature in part because it is straightforward to measure. But new gauges of affordability are needed to capture future risks (including that of underconsumption) as well as past burdens, and tackle numerous other conceptual difficulties such as a recent National Research Council and Institute of Medicine report outlines (2012).
Along with better measurements is the need for accurate data, ideally collected to permit international comparisons. The dual need for more robust measures backed by good data can be inferred by the existence of high levels of OOP spending despite policies in most countries to limit them (Paris Devaux and Wei 2010; The Commonwealth Fund Nov 2013) . The complex nature of health care and health insurance design, and the various ways in which consumers respond to its quality, convenience, and range of choices can result in higher-than-expected OOP spending in practice (Rosenthal 2015; Domenighetti et al 2010) . Developing measures and data sources allowing cross-national comparisons, such as advocated by numerous international organizations (Rannan-Eliya and Lorenzoni, 2010) , could foster more rigorous and comprehensive analyses of health insurance design, analyses that would also improve assessments of the relative performance of health care systems and the role of OOP expenditures in it. (2010) Civilian non-institutional population in the United States.
Variable capturing spending on health insurance premiums is hmxvcs.
Notes:
Weighting: all calculations are based on weighted values using "ppopwgt" variable. Out of pocket spending Bottom coding: All negative values for disposable income (dhi) or out-of-pocket spending (hcmed or hmcmed) bottom-coded to zero.
